Published in BMC Hematol on April 11, 2013
Immunoglobulin replacement therapy in secondary hypogammaglobulinemia. Front Immunol (2014) 0.83
International consensus report on the investigation and management of primary immune thrombocytopenia. Blood (2009) 7.72
Humoral immunity due to long-lived plasma cells. Immunity (1998) 6.35
The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood (2007) 4.14
Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood (2008) 3.44
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol (2007) 2.98
Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med (2007) 2.97
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol (1998) 2.57
CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today (1994) 2.25
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum (2012) 2.05
A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol (2008) 1.86
Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol (2011) 1.60
Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood (2002) 1.59
"A rose is a rose is a rose," but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol (2011) 1.49
Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep (2009) 1.49
CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry (1993) 1.46
B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol (2010) 1.39
Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol (2000) 1.35
Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun (2005) 1.27
Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol (2008) 1.24
Delayed-onset neutropenia associated with rituximab therapy. Br J Haematol (2003) 1.22
Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) (2004) 1.21
Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol (2010) 1.10
High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency. Clin Immunol (2007) 1.08
Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura. Clin Immunol (2008) 1.07
Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immunol (2009) 1.07
B-cell depletion in the treatment of lupus nephritis. Nat Rev Nephrol (2012) 1.05
Primary immunodeficiencies (PIDs) presenting with cytopenias. Hematology Am Soc Hematol Educ Program (2009) 1.05
Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency. Clin Immunol (2010) 1.03
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol (2011) 1.00
Does rituximab aggravate pre-existing hypogammaglobulinaemia? J Clin Pathol (2010) 0.96
Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann N Y Acad Sci (2005) 0.93
Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma. Eur J Haematol (2006) 0.91
Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma. Cancer Invest (2008) 0.90
Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency. Am J Hematol (2006) 0.89
Influence of age, gender and lifestyle in lymphocyte subsets: report from the Spanish Gait-2 Study. Acta Haematol (2012) 0.85
Successful use of rituximab in refractory idiopathic thrombocytopenic purpura in a patient with common variable immunodeficiency. J Investig Allergol Clin Immunol (2010) 0.84
Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia. Eur J Haematol (2005) 0.83
Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab. J Clin Pathol (2007) 0.80
Common variable immunodeficiency and hemophagocytic features associated with a FAS gene mutation. J Allergy Clin Immunol (2011) 0.79
[Primary immunodeficiencies presenting with autoimmune cytopenias in adults]. Rev Med Interne (2012) 0.78
Double-negative T cells are non-ALPS-specific markers of immune dysregulation found in patients with aplastic anemia. Blood (2010) 0.78
Rituximab for relapsing-remitting multiple sclerosis. Cochrane Database Syst Rev (2011) 0.78
[Atypical presentation of common variable immunodeficiency without infections]. Allergol Immunopathol (Madr) (2004) 0.76
New therapies for immune thrombocytopenic purpura. Curr Opin Hematol (2007) 0.76
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell (2010) 4.07
Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis (2007) 2.69
Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis (2012) 2.39
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med (2005) 2.36
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias. Blood (2013) 2.16
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest (2013) 1.72
Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur J Haematol (2006) 1.55
Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun (2005) 1.46
Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma. Eur J Haematol (2007) 1.46
Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. AIDS (2012) 1.45
Innate immune recognition and activation during HIV infection. Retrovirology (2010) 1.45
Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS One (2011) 1.42
WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study. Br J Haematol (2004) 1.36
Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis (2005) 1.33
Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLoS One (2012) 1.30
Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population. AIDS (2004) 1.24
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends Immunol (2003) 1.23
Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood (2002) 1.22
The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine (2007) 1.16
Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis. Proc Natl Acad Sci U S A (2008) 1.14
Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma. Cancer Immunol Immunother (2004) 1.12
Retention in a public healthcare system with free access to treatment: a Danish nationwide HIV cohort study. AIDS (2012) 1.10
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy. Br J Haematol (2010) 1.09
Acute demyelinizating encephalomyelitis (ADEM) as initial presentation of primary HIV infection. Scand J Infect Dis (2007) 1.08
Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals. AIDS (2005) 1.06
Interleukin-21 mRNA expression during virus infections. Cytokine (2006) 1.06
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome. Clin Cancer Res (2007) 1.06
Persistence of DNMT3A mutations at long-term remission in adult patients with AML. Br J Haematol (2014) 1.05
Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS (2014) 1.05
Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias. Blood (2009) 1.03
Profile of illness in Syrian refugees: A GeoSentinel analysis, 2013 to 2015. Euro Surveill (2016) 1.02
Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. Eur J Haematol (2008) 1.01
Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study. PLoS One (2013) 1.01
Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene. Epigenetics Chromatin (2008) 0.99
Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC Infect Dis (2010) 0.98
Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study. Addiction (2010) 0.98
Lung cancer in HIV patients and their parents: a Danish cohort study. BMC Cancer (2011) 0.98
ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood (2002) 0.97
Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients. Br J Haematol (2004) 0.97
Polymorphisms in the genes ERCC2, XRCC3 and CD3EAP influence treatment outcome in multiple myeloma patients undergoing autologous bone marrow transplantation. Int J Cancer (2007) 0.97
Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007. BMC Pulm Med (2011) 0.97
TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells. J Immunol (2009) 0.95
Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms. Mod Pathol (2008) 0.94
Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells. Blood (2013) 0.93
T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging. J Immunother (2007) 0.93
Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML. Blood (2012) 0.92
Chronic hepatitis caused by persistent parvovirus B19 infection. BMC Infect Dis (2010) 0.91
Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study. J Acquir Immune Defic Syndr (2016) 0.91
Is there an association between rumination and self-reported physical health? A one-year follow-up in a young and an elderly sample. J Behav Med (2004) 0.89
The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML. Eur J Haematol (2009) 0.88
Employment status in persons with and without HIV infection in Denmark: 1996-2011. AIDS (2014) 0.87
Accumulation in tumor tissue of adoptively transferred T cells: A comparison between intravenous and intraperitoneal injection. J Immunother (2006) 0.86
Educational attainment and risk of HIV infection, response to antiretroviral treatment, and mortality in HIV-infected patients. AIDS (2014) 0.85
Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up. Cytometry B Clin Cytom (2011) 0.85
Polymorphism in interleukin-7 receptor α gene is associated with faster CD4⁺ T-cell recovery after initiation of combination antiretroviral therapy. AIDS (2014) 0.85
Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings. Rheumatol Int (2010) 0.84
hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia. Br J Haematol (2013) 0.84
A pharmacodynamic study of 5-azacytidine in the P39 cell line. Exp Hematol (2006) 0.84
Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia. Eur J Haematol (2013) 0.84
Negative thoughts and health: associations among rumination, immunity, and health care utilization in a young and elderly sample. Psychosom Med (2004) 0.84
Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen. Clin Epidemiol (2010) 0.84
Adherence to national guidelines for initiation of antiretroviral regimens in HIV patients: a Danish nationwide study. Br J Clin Pharmacol (2011) 0.84
CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV. Clin Infect Dis (2013) 0.84
Misdiagnosed amoebic colitis leading to severe dysentery and necrotizing colitis--report of a case and review of the literature. Scand J Infect Dis (2014) 0.83
Natural killer cells: from "disturbing" background to central players of immune responses. Mol Immunol (2005) 0.83
Persistent altered fusion transcript splicing identifies RUNX1-RUNX1T1+ AML patients likely to relapse. Eur J Haematol (2009) 0.83
WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder. Leuk Res (2005) 0.83
The impact of B-cell perturbations on pneumococcal conjugate vaccine response in HIV-infected adults. PLoS One (2012) 0.83
Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene. Br J Haematol (2014) 0.82
Short-term exposure to human cytomegalovirus-infected fibroblasts induces a proportional increase of active CD94/NKG2A(+) natural killer cells. Hum Immunol (2010) 0.82
Expression levels of hsc70 and hsp60 are developmentally regulated during B-cell maturation and not associated to childhood c-ALL at presentation or relapse. Eur J Haematol (2003) 0.81
Poor CD4 response despite viral suppression is associated with increased non-AIDS-related mortality among HIV patients and their parents. AIDS (2013) 0.81
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis. Acta Haematol (2012) 0.81
Nature and nurture: a case of transcending haematological pre-malignancies in a pair of monozygotic twins adding possible clues on the pathogenesis of B-cell proliferations. Br J Haematol (2015) 0.81
Minimal engraftment of human CD34+ cells mobilized from healthy donors in the infarcted heart of athymic nude rats. Stem Cells Dev (2009) 0.81
Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts. Br J Haematol (2006) 0.81
Nonviral transfection of leukemic primary cells and cells lines by siRNA-a direct comparison between Nucleofection and Accell delivery. Exp Hematol (2011) 0.80
Genetic and epigenetic similarities and differences between childhood and adult AML. Pediatr Blood Cancer (2011) 0.80
Tumour-associated macrophages are related to progression in patients with metastatic melanoma following interleukin-2 based immunotherapy. Acta Oncol (2006) 0.79
A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma. Eur J Haematol (2012) 0.79
Changing picture of cellular drug resistance in human leukemia. Crit Rev Oncol Hematol (2004) 0.79
Fas ligand expression in metastatic renal cell carcinoma during interleukin-2 based immunotherapy: no in vivo effect of Fas ligand tumor counterattack. Clin Cancer Res (2004) 0.79
Mitochondrial cytochrome c oxidase subunit II variations predict adverse prognosis in cytogenetically normal acute myeloid leukaemia. Eur J Haematol (2013) 0.79
Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma. Pediatr Blood Cancer (2006) 0.79
Head and neck cancer in HIV patients and their parents: a Danish cohort study. Clin Epidemiol (2011) 0.79
Anal carcinoma in HIV-infected patients in the period 1995-2009: a Danish nationwide cohort study. Scand J Infect Dis (2013) 0.79
Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age. Br J Haematol (2014) 0.79
Identification of a novel STAT3 mutation in a patient with hyper-IgE syndrome. Scand J Infect Dis (2012) 0.79
Detection of circulating tumor lysate-reactive CD4+ T cells in melanoma patients. Cancer Immunol Immunother (2004) 0.78
[Changes in immunological status among newly-diagnosed HIV-infected in Denmark 1995-2005]. Ugeskr Laeger (2008) 0.78
Differential associations between white blood cell counts and fatigue in young and older adults. Aging Clin Exp Res (2012) 0.78
Leukocyte, plasma, and organ-associated cytokine profiles in an animal model of acute inflammation. APMIS (2008) 0.78
Increased expression of CD69 on T cells as an early immune marker for human cytomegalovirus reactivation in chronic lymphocytic leukemia patients. Viral Immunol (2011) 0.78
Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology. Br J Haematol (2013) 0.78